Page last updated: 2024-12-11
l 689660
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6439472 |
SCHEMBL ID | 194353 |
MeSH ID | M0205223 |
Synonyms (13)
Synonym |
---|
l-689660 |
3-(2-6-chloropyrazinyl)-1-azabicyclo(2.2.2)octane |
1-azabicyclo(2.2.2)octane, 3-(6-chloropyrazinyl)-, (z)-2-butenedioate |
144860-79-7 |
l-689,660 |
3-(6-chloropyrazinyl)-1-azabicyclo(2.2.2)octane (z)-2-butenedioate |
l 689660 |
SCHEMBL194353 |
3-(6-chloropyrazin-2-yl)quinuclidine xmaleate |
l689660 |
3-(6-chloropyrazin-2-yl)quinuclidine maleate |
(z)-but-2-enedioic acid;3-(6-chloropyrazin-2-yl)-1-azabicyclo[2.2.2]octane |
AKOS040752322 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |